Expertise in
5
conditions

Dr. Jonas A. De Souza

Hematology | Oncology
Office
5200 S Ellis Ave Apt 118N, 
Chicago, IL 
Expertise in
5
conditions
Office
5200 S Ellis Ave Apt 118N, 
Chicago, IL 

Overview

Jonas De Souza is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois.

Dr. De Souza is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC).

He is actively involved in clinical research, co-authoring 53 peer reviewed articles and participating in 6 clinical trials.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in IL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
5200 S Ellis Ave Apt 118N, Chicago, IL 60615

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Phase II Trial of Sunitinib (SU11248) in Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers and Medullary Thyroid Cancers
Phase II Trial of Sunitinib (SU11248) in Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers and Medullary Thyroid Cancers
Enrollment Status: Completed
Publish Date: March 28, 2025
Intervention Type: Drug, Other
Study Drugs: Sunitinib, Sunitinib Malate
Study Phase: Phase 2
Nab-Paclitaxel-based Re-induction Chemotherapy Followed by Response-stratified Chemoradiotherapy in Patients With Previously Treated Squamous Cell Carcinoma of the Head and Neck.
Nab-Paclitaxel-based Re-induction Chemotherapy Followed by Response-stratified Chemoradiotherapy in Patients With Previously Treated Squamous Cell Carcinoma of the Head and Neck.
Enrollment Status: Completed
Publish Date: July 31, 2024
Intervention Type: Procedure, Drug, Radiation, Other
Study Drugs: Carboplatin, Paclitaxel, 5-Fluorouracil, Hydroxyurea
Study Phase: Phase 1
Carboplatin-Paclitaxel Induction Chemotherapy and ABT-888 (Veliparib) - a Phase 1/Randomized Phase 2 Study in Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
Carboplatin-Paclitaxel Induction Chemotherapy and ABT-888 (Veliparib) - a Phase 1/Randomized Phase 2 Study in Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
Enrollment Status: Completed
Publish Date: June 07, 2023
Intervention Type: Other, Drug, Radiation
Study Drugs: Carboplatin, Cisplatin, 5-Fluorouracil, Hydroxyurea, Paclitaxel, Veliparib
Study Phase: Phase 1/Phase 2
Phase I/II Trial of Cediranib Alone or Cediranib and Lenalidomide in Iodine 131-Refractory Differentiated Thyroid Cancer
Phase I/II Trial of Cediranib Alone or Cediranib and Lenalidomide in Iodine 131-Refractory Differentiated Thyroid Cancer
Enrollment Status: Completed
Publish Date: July 15, 2021
Intervention Type: Other, Drug
Study Drugs: Cediranib, Cediranib Maleate, Lenalidomide
Study Phase: Phase 1/Phase 2
Randomized Placebo- Controlled Pilot Study of ZD6474 as a Chemopreventive Agent for Premalignant Lesions of the Head and Neck
Randomized Placebo- Controlled Pilot Study of ZD6474 as a Chemopreventive Agent for Premalignant Lesions of the Head and Neck
Enrollment Status: Completed
Publish Date: January 14, 2021
Intervention Type: Other, Procedure, Drug
Study Phase: Phase 2
A Pilot Feasibility Study of 99mTc EC DG SPECT/CT Imaging in the Treatment Response Evaluation in Patients With Locally Advanced Head and Neck Cancer
A Pilot Feasibility Study of 99mTc EC DG SPECT/CT Imaging in the Treatment Response Evaluation in Patients With Locally Advanced Head and Neck Cancer
Enrollment Status: Completed
Publish Date: May 08, 2020
Intervention Type: Drug
Study Phase: Early Phase 1
View 5 Less Clinical Trials

53 Total Publications

Invited review: Moving from dietary fat to fatty acids-New insights into how fatty acids affect digestibility, metabolism, and performance in dairy cows.
Invited review: Moving from dietary fat to fatty acids-New insights into how fatty acids affect digestibility, metabolism, and performance in dairy cows.
Journal: Journal of dairy science
Published: June 03, 2025
Similar Doctors
Expertise in
25
conditions
Dr. Sonali M. Smith
Hematology | Oncology
Expertise in
25
conditions
Dr. Sonali M. Smith
Hematology | Oncology
Referral may be required

UChicago Medicine River East

355 E. Grand Ave., 
Chicago, IL 
 (6.3 miles away)
888-824-0200
Languages Spoken:
English, Greek, Gujarati , Hindi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Sonali Smith is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Smith is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Smith is board certified in Medical Oncology and Practicing Since2001. Dr. Smith is currently accepting new patients.

Expertise in
33
conditions
Dr. Leo I. Gordon
Hematology | Oncology
Expertise in
33
conditions
Dr. Leo I. Gordon
Hematology | Oncology
Referral may be required
Before you request
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
 (6.6 miles away)
866-587-4322
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Leo Gordon is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Gordon is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Gordon is board certified in American Board Of Internal Medicine - Hematology (Certified). Dr. Gordon is currently accepting new patients.

Expertise in
17
conditions
Dr. Jessica K. Altman
Hematology | Oncology
Expertise in
17
conditions
Dr. Jessica K. Altman
Hematology | Oncology
Referral may be required
Before you request
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
 (6.6 miles away)
866-587-4322
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jessica Altman is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Altman is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Altman is board certified in American Board Of Internal Medicine - Hematology (Certified). Dr. Altman is currently accepting new patients.

Frequently Asked Questions about Dr. Jonas A. De Souza

How do I make an appointment with Dr. Jonas A. De Souza?

You can book an appointment with Dr. Jonas A. De Souza by calling their office at 713-301-9530. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jonas A. De Souza a top-rated expert for Thyroid Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jonas A. De Souza is classified as an Advanced expert for Thyroid Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jonas A. De Souza specialize in?

While Dr. Jonas A. De Souza is a Hematology, they have specific expertise in Thyroid Cancer, Follicular Thyroid Cancer, and Papillary Thyroid Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Jonas A. De Souza participate in research or clinical trials?

Yes. Dr. Jonas A. De Souza has published 53 articles and abstracts on conditions like Thyroid Cancer. You can view a list of Dr. Jonas A. De Souza's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. De Souza's expertise for a condition
ConditionClose
      View All 24 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile